Shenyang, Liaoning province-based Chinese bio-pharmaceutical firm 3SBio Inc., backed by CITIC Private Equity Funds Management Co. (CITIC PE), is seeking to raise as much as US$712 million in a Hong Kong initial public offering, according to a securities filing. The company is offering 606.1 million shares at HK$8.30 to HK$9.10 apiece, with a valuation of […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.